Difference between revisions of "Crystallin"
m |
|||
| (6 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | | + | | align="center" colspan="2" bgcolor="#ffffff" | |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 14: | Line 14: | ||
|- | |- | ||
| Source | | Source | ||
| − | | Bos taurus | + | | Bos taurus |
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
| Line 21: | Line 21: | ||
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
| − | | [http://au.expasy.org/uniprot/P02511 P02511 ] | + | | [http://au.expasy.org/uniprot/P02511 P02511] |
| − | + | [http://au.expasy.org/uniprot/P02522 P02522 ] | |
| − | + | [http://au.expasy.org/uniprot/P19141 P19141 ] | |
| − | + | [http://au.expasy.org/uniprot/P11843 P11843 ] | |
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| Line 54: | Line 54: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| Line 66: | Line 66: | ||
| | | | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:31, 10 March 2015
| Crystallin | |
|---|---|
| Substrate peptide name | Crystallin |
| Synonyms | - |
| Determination type | In vitro |
| Source | Bos taurus |
| Subcellular localization | In lens it is associated to cytoskeleton and plasma membrane, outside the lens it has cytosolic/nuclear localization |
| Swissprot ID | P02511 |
| Reactive glutamines | Beta B2 – Q9
Beta B3 – Q21 Beta A3 – Q23/24 |
| Reactive lysines | Beta A3 – K33
Alpha B – K175 |
| Substrate sequence | β B2 – SDHETQAGKPQ
β B3 – AEQHSTPE β A3 – ETQTVQQELESL β A3 – SLPTTKMAQTN α B - TAAPKK |
| Structure | 2BB2 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:1349282 |
| Notes | |
